Human papillomavirus 18 E1∧E4 protein interacts with cyclin A/CDK 2 through an RXL motif

Molecular and Cellular Biochemistry

Volumn 373, Issue 1-2, 2013, Pages 29-40

  Ding, Qingming ^a,b   Li, Lili ^a,c   Whyte, Peter ^a  

^a MCMASTER UNIVERSITY   (Canada)

^b ROBARTS RESEARCH INSTITUTE   (Canada)

^c MCGILL UNIVERSITY   (Canada)

Author keywords

Cell cycle; Cyclin dependent kinase; Cyclins; E4; HPV18; Human papillomavirus; Phosphorylation

Indexed keywords

CELL EXTRACT; CYCLIN A; CYCLIN DEPENDENT KINASE 2; CYCLIN E; MELANOMA ANTIGEN 4; RXL PROTEIN; UNCLASSIFIED DRUG; VIRUS PROTEIN;

ARTICLE; BACULOVIRUS; CANCER CELL CULTURE; CONTROLLED STUDY; GENE SEQUENCE; HOST CELL; HUMAN; HUMAN CELL; HUMAN PAPILLOMAVIRUS TYPE 18; MAMMAL CELL; PAPILLOMAVIRUS INFECTION; PROTEIN INTERACTION; PROTEIN MOTIF; PROTEIN PHOSPHORYLATION; PROTEIN PROTEIN INTERACTION; UTERINE CERVIX CARCINOMA; VIRUS CELL INTERACTION; VIRUS DETECTION; VIRUS GENE; VIRUS GENOME;

AMINO ACID SEQUENCE; ANIMALS; BINDING, COMPETITIVE; CELL LINE, TUMOR; CYCLIN A; CYCLIN-DEPENDENT KINASE 2; HUMAN PAPILLOMAVIRUS 18; HUMANS; MOLECULAR SEQUENCE DATA; ONCOGENE PROTEINS, VIRAL; PEPTIDE FRAGMENTS; PHOSPHORYLATION; PROTEIN BINDING; PROTEIN INTERACTION DOMAINS AND MOTIFS; PROTEIN KINASES; PROTEIN PROCESSING, POST-TRANSLATIONAL; SF9 CELLS; SPODOPTERA;

HUMAN PAPILLOMAVIRUS; HUMAN PAPILLOMAVIRUS - 18; MAMMALIA;

EID: 84871802398     PISSN: 03008177     EISSN: 15734919     Source Type: Journal    
DOI: 10.1007/s11010-012-1472-y     Document Type: Article

References (57)

1. de Villiers EM, Fauquet C, Broker TR, Bernard HU, zur Hausen H (2004) Classification of papillomaviruses. Virology 324(1):17-27. doi: 10.1016/j.virol.2004.03.033
2. Walboomers JM, Jacobs MV, Manos MM, Bosch FX, Kummer JA, Shah KV, Snijders PJ, Peto J, Meijer CJ, Munoz N (1999) Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. J Pathol 189(1):12-19. doi: 10.1002/(SICI)1096-9896(199909)189
3. Hebner CM, Laimins LA (2006) Human papillomaviruses: basic mechanisms of pathogenesis and oncogenicity. Rev Med Virol 16(2):83-97. doi: 10.1002/rmv.488
4. Crum CP, Nuovo G, Friedman D, Silverstein SJ (1988) Accumulation of RNA homologous to human papillomavirus type 16 open reading frames in genital precancers. J Virol 62(1):84-90
5. Doorbar J, Foo C, Coleman N, Medcalf L, Hartley O, Prospero T, Napthine S, Sterling J, Winter G, Griffin H (1997) Characterization of events during the late stages of HPV16 infection in vivo using high-affinity synthetic Fabs to E4. Virology 238(1):40-52. doi: 10.1006/viro.1997.8768
6. Middleton K, Peh W, Southern S, Griffin H, Sotlar K, Nakahara T, El-Sherif A, Morris L, Seth R, Hibma M, Jenkins D, Lambert P, Coleman N, Doorbar J (2003) Organization of human papillomavirus productive cycle during neoplastic progression provides a basis for selection of diagnostic markers. J Virol 77(19):10186-10201
7. Stoler MH, Wolinsky SM, Whitbeck A, Broker TR, Chow LT (1989) Differentiation-linked human papillomavirus types 6 and 11 transcription in genital condylomata revealed by in situ hybridization with message-specific RNA probes. Virology 172(1):331-340
8. Chow LT, Nasseri M, Wolinsky SM, Broker TR (1987) Human papillomavirus types 6 and 11 mRNAs from genital condylomata acuminata. J Virol 61:2581-2588
9. Nasseri M, Hirochika R, Broker TR, Chow LT (1987) A human papilloma virus type 11 transcript encoding an E1∧E4 protein. Virology 159:433-439
10. Nakahara T, Peh WL, Doorbar J, Lee D, Lambert PF (2005) Human papillomavirus type 16 E1∧E4 contributes to multiple facets of the papillomavirus life cycle. J Virol 79(20):13150-13165
11. Wilson R, Fehrmann F, Laimins LA (2005) Role of the E1∧E4 protein in the differentiation-dependent life cycle of human papillomavirus type 31. J Virol 79(11):6732-6740
12. Wilson R, Ryan GB, Knight GL, Laimins LA, Roberts S (2007) The full-length E1∧E4 protein of human papillomavirus type 18 modulates differentiation-dependent viral DNA amplification and late gene expression. Virology 362(2):453-460. doi: 10.1016/j.virol.2007.01.005
13. Fang L, Budgeon LR, Doorbar J, Briggs ER, Howett MK (2006) The human papillomavirus type 11 E1∧E4 protein is not essential for viral genome amplification. Virology 351(2):271-279
14. Peh WL, Brandsma JL, Christensen ND, Cladel NM, Wu X, Doorbar J (2004) The viral E4 protein is required for the completion of the cottontail rabbit papillomavirus productive cycle in vivo. J Virol 78(4):2142-2151
15. Davy CE, Jackson DJ, Wang Q, Raj K, Masterson PJ, Fenner NF, Southern S, Cuthill S, Millar JBA, Doorbar J (2002) Identification of a G2 arrest domain in the E1∧E4 protein of human papillomavirus type 16. J Virol 76:9806-9818
16. Knight GL, Grainger JR, Gallimore PH, Roberts S (2004) Cooperation between different forms of the human papillomavirus type 1 E4 protein to block cell cycle progression and cellular DNA synthesis. J Virol 78(24):13920-13933
17. Nakahara T, Nishimura A, Tnaka M, Ueno T, Ishimoto A, Sakai H (2002) Modulation of the cell division cycle by human papillomavirus type 18 E4. J Virol 76:10914-10920
18. Davy CE, Ayub M, Jackson DJ, Das P, McIntosh P, Doorbar J (2006) HPV16 E1∧E4 protein is phosphorylated by Cdk2/cyclin A and relocalizes this complex to the cytoplasm. Virology 349(1):230-244
19. Davy CE, Jackson DJ, Raj K, Peh WL, Southern SA, Das P, Sorathia R, Laskey P, Middleton K, Nakahara T, Wang Q, Masterson PJ, Lambert PF, Cuthill S, Millar JB, Doorbar J (2005) Human papillomavirus type 16 E1∧E4-induced G2 arrest is associated with cytoplasmic retention of active Cdk1/cyclin B1 complexes. J Virol 79(7):3998-4011
20. Doorbar J, Medcalf E, Napthine S (1996) Analysis of HPV1 E4 complexes and their association with keratins in vivo. Virology 218:114-126
21. Douglas JL, Gopalakrishnan S, Quinlan MP (1991) Modulation of transformation of primary epithelial cells by the second exon of the Ad5 E1A12S gene. Oncogene 6(11):2093-2103
22. Roberts S, Ashmole I, Gibson LJ, Rookes SM, Barton GJ, Gallimore PH (1994) Mutational analysis of human papillomavirus E4 proteins: identification of structural features important in the formation of cytoplasmic E4/cytokeratin networks in epithelial cells. J Virol 68(10):6432-6445
23. Wang Q, Griffin H, Southern S, Jackson D, Martin A, McIntosh P, Davy C, Masterson PJ, Walker PA, Laskey P, Omary MB, Doorbar J (2004) Functional analysis of the human papillomavirus type 16 E1∧E4 protein provides a mechanism for in vivo and in vitro keratin filament reorganization. J Virol 78(2):821-833
24. Bell I, Martin A, Roberts S (2007) The E1∧E4 protein of human papillomavirus interacts with the serine-arginine-specific protein kinase SRPK1. J Virol 81(11):5437-5448. doi: 10.1128/JVI.02609-06
25. Wang Q, Kennedy A, Das P, McIntosh PB, Howell SA, Isaacson ER, Hinz SA, Davy C, Doorbar J (2009) Phosphorylation of the human papillomavirus type 16 E1∧E4 protein at T57 by ERK triggers a structural change that enhances keratin binding and protein stability. J Virol 83(8):3668-3683. doi: 10.1128/JVI.02063-08
26. Doorbar J, Elston RC, Napthine S, Raj K, Medcalf E, Jackson DJ, Coleman N, Griffin HM, Masterson PJ, Stacey S, Mengistru Y, Dunlop J (2000) The E1∧E4 protein of human papillomavirus type 16 associates with a putative RNA helicase through sequences in its C terminus. J Virol 74:10081-10095
27. Raj K, Berguerand S, Southern S, Doorbar J, Beard P (2004) E1∧E4 protein of human papillomavirus type 16 associates with mitochondria. J Virol 78(13):7199-7207
28. Roberts S, Hillman ML, Knight GL, Gallimore PH (2003) The ND10 component promyelocytic leukemia protein relocates to human papillomavirus type 1 E4 intranuclear inclusion bodies in cultured keratinocytes and in warts. J Virol 77(1):673-684
29. Ma T, Zou N, Lin BY, Chow LT, Harper JW (1999) Interaction between cyclin-dependent kinases and human papillomavirus replication-initiation protein E1 is required for efficient viral replication. Proc Natl Acad Sci USA 96:382-387
30. Sherr CJ (1996) Cancer cell cycles. Science 274:1672-1677
31. Adams PD, Sellers WR, Sharma SK, Wu AD, Nalin CM, Kaelin WG (1996) Identification of a cyclin/cdk2 recognition motif present in substrates and p21-like-dependent kinase inhibitors. Mol Cell Biol 16:6623-6633
32. CIP1. Mol Cell Biol 16:4673-4682
33. Krek W, Xu G, Livingston DM (1995) Cyclin A-kinase regulation of E2F-1 DNA binding function underlies suppression of an S phase checkpoint. Cell 83:1149-1158
34. Lacy S, Whyte P (1997) Identification of a region of p130 mediating interactions with cyclin A/cdk2 and cyclin E/cdk2 complexes. Oncogene 14:2395-2406
35. Lin J, Reichner C, Wu X, Levine AJ (1996) Analysis of wild-type and mutant p21WAF-1 gene activities. Mol Cell Biol 16:1786-1793
36. kip1 cyclin-dependent-kinase inhibitor bound to the cyclin A-Cdk2 complex. Nature 382:325-331
37. Zhu L, Harlow E, Dynlacht BD (1995) p107 uses a p21cip1-related domain to bind cyclin/cdk2 and regulate interactions with E2F. Genes Dev 9:1740-1752
38. Lowe ED, Tews I, Cheng KY, Brown NR, Gul S, Noble ME, Gamblin SJ, Johnson LN (2002) Specificity determinants of recruitment peptides bound to phospho-CDK2/cyclin A. Biochemistry 41(52):15625-15634
39. Russo AA, Jeffrey PD, Patten AK, Massague J, Pavletich NP (1996) Crystal structure of the p27Kip1 cyclin-dependent-kinase inhibitor bound to the cyclin A-Cdk2 complex. Nature 382(6589):325-331. doi: 10.1038/382325a0
40. Loog M, Morgan DO (2005) Cyclin specificity in the phosphorylation of cyclin-dependent kinase substrates. Nature 434(7029):104-108. doi: 10.1038/nature03329
41. Miller ME, Cross FR (2001) Cyclin specificity: how many wheels do you need on a unicycle? J Cell Sci 114(Pt 10):1811-1820
42. Dynlacht BD, Flores O, Lees JA, Harlow E (1994) Differential regulation of E2F transactivation by cyclin/cdk2 complexes. Genes Dev 8(15):1772-1786
43. Petersen BO, Lukas J, Sorensen CS, Bartek J, Helin K (1999) Phosphorylation of mammalian CDC6 by cyclin A/CDK2 regulates its subcellular localization. EMBO J 18:396-410
44. Peeper DS, Parker LL, Ewen ME, Toebes M, Hall FL, Xu M, Zantema A, van der Eb AJ, Piwinica-Worms H (1993) A and B type cyclins differentially modulate substrate specificity of cyclin-cdk complexes. EMBO J 12:1947-1954
45. Brown DR, Bryan JT, Pratt L, Handy V, Fife KH, Stoler MH (1995) Human papillomavirus type 11 E1∧E4 and L1 proteins colocalize in the mouse xenograft system at multiple time points. Virology 214(1):259-263
46. Doorbar J, Campbell D, Grand RJ, Gallimore PH (1986) Identification of the human papilloma virus-1a E4 gene products. EMBO J 5(2):355-362
47. Doorbar J, Ely S, Sterling J, McLean C, Crawford L (1991) Specific interaction between HPV16 E1-E4 and cytokeratins results in collapse of the epithelial cell intermediate filament network. Nature 352:824-827
48. Palefsky JM, Winkler B, Raqbanus JP, Clark C, Chan S, Nizet V, Nizet V, Schoolnik GK (1991) Characterization of in vivo expression of the human papillomavirus type 16 E4 protein in cervical biopsy tissues. J Clin Invest 87:2132-2141
49. Pray TR, Laimins LA (1995) Differentiation-dependent expression of E1∧E4 proteins in cell lines maintaining episomes of human papillomavirus type 31b. Virology 206:679-685
50. Rogel-Gaillard C, Breitburd F, Orth G (1992) Human papillomavirus type 1 E4 proteins differing by their N-terminal ends have distinct cellular localizations when transiently expressed in vitro. J Virol 66:816-823
51. Woo RA, Poon RY (2003) Cyclin-dependent kinases and S phase control in mammalian cells. Cell Cycle 2(4):316-324
52. Knight GL, Pugh AG, Yates E, Bell I, Wilson R, Moody CA, Laimins LA, Roberts S (2011) A cyclin-binding motif in human papillomavirus type 18 (HPV18) E1∧E4 is necessary for association with CDK-cyclin complexes and G2/M cell cycle arrest of keratinocytes, but is not required for differentiation-dependent viral genome amplification or L1 capsid protein expression. Virology 412(1):196-210. doi: 10.1016/j.virol.2011.01.007
53. Knight GL, Turnell AS, Roberts S (2006) Role for Wee1 in inhibition of G2-to-M transition through the cooperation of distinct human papillomavirus type 1 E4 proteins. J Virol 80(15):7416-7426
54. Guida P, Zhu L (1999) DP1 phosphorylation in multimeric complexes: weaker interaction with cyclin A through the E2F1 cyclin A binding domain leads to more efficient phosphorylation than stronger interaction through the p107 cyclin A binding domain. Biochem Biophys Res Commun 258(3):596-604. doi: 10.1006/bbrc.1999.0656
55. Desai D, Gu Y, D.O. M (1992) Activation of human cyclin-dependent kinases in vitro. Mol Biol Cell 3:571-582
56. Graham FL, Van Der Eb AJ (1973) A new technique for the assay of infectivity of human adenovirus. Virology 52:456-467
57. Giordano A, Whyte P, Harlow E, Franza BRJ, Beach D, Draetta G (1989) A 60 kd cdc2-associated polypeptide complexes with the E1A proteins in adenovirus-infected cells. Cell 58:981-990